{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:26Z","timestamp":1791230726631,"version":"4.1.0"},"reference-count":218,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Drug-induced osteoporosis is considered secondary osteoporosis caused by pharmacological drugs that can alter the diversity and function of the gut microbiota (GM), which in turn may be associated with the development or exacerbation of osteoporosis. This review uncovers the relationship between drug-induced osteoporosis and GM based on preclinical and clinical studies. In this context, we focused on secondary osteoporosis induced by glucocorticoids, aromatase inhibitors, proton pump inhibitors, antiretroviral drugs, antiepileptic drugs, antipsychotics, antidepressants, and subsequent alterations in the GM. Different pharmacological drugs can induce secondary osteoporosis through multiple mechanisms, and some of them exert similar mechanisms of their harmful effect on bone health, including decreased osteoblastogenesis, increased osteoclastogenesis, disturbances in calcium and vitamin D metabolism, alterations in hormone and cytokine levels. In addition, diverse drugs can significantly reshape gut microbial communities, often in a drug- and context-specific manner. However, the mechanisms linking individual drugs, GM, and bone health are still largely unresolved. There is little or no direct evidence that drug-induced GM alterations mediate changes in bone turnover, bone mineral density (BMD), or fracture risk for most of the drug classes mentioned. Observational and interventional clinical studies in this area are necessary to provide conclusive evidence of the association between drug-induced osteoporosis and GM. Therapeutic approaches that have shown promise in the treatment of medication-induced osteoporosis include pharmacological interventions, adequate calcium and vitamin D intake, weight-bearing exercise, and preventive monitoring of BMD. Probiotic and prebiotic supplementation may be a future option if supported by compelling clinical evidence.<\/jats:p>","DOI":"10.3389\/fendo.2026.1818207","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:28Z","timestamp":1780287568000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Linking the relationship between drug-induced osteoporosis and the gut microbiota"],"prefix":"10.3389","volume":"17","author":[{"given":"Monika","family":"Martiniakova","sequence":"first","affiliation":[{"name":"Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra","place":["Nitra, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sarocka","sequence":"additional","affiliation":[{"name":"Department of Botany and Genetics, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra","place":["Nitra, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Penzes","sequence":"additional","affiliation":[{"name":"Department of Botany and Genetics, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra","place":["Nitra, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimira","family":"Mondockova","sequence":"additional","affiliation":[{"name":"Department of Botany and Genetics, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra","place":["Nitra, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Sevcikova","sequence":"additional","affiliation":[{"name":"Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences","place":["Bratislava, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Ciernikova","sequence":"additional","affiliation":[{"name":"Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences","place":["Bratislava, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Kovacova","sequence":"additional","affiliation":[{"name":"Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra","place":["Nitra, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Biro","sequence":"additional","affiliation":[{"name":"Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra","place":["Nitra, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Folwarczna","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice","place":["Sosnowiec, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Omelka","sequence":"additional","affiliation":[{"name":"Department of Botany and Genetics, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra","place":["Nitra, Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030523","article-title":"The role of macronutrients, micronutrients and flavonoid polyphenols in the prevention and treatment of osteoporosis","volume":"14","author":"Martiniakova","year":"2022","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1409534","article-title":"A decade of insight: bibliometric analysis of gut microbiota\u2019s role in osteoporosis (2014-2024)","volume":"11","author":"Luo","year":"2024","journal-title":"Front Med Lausanne"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-06240-7","article-title":"The global approach to rehabilitation following an osteoporotic fragility fracture: a review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors","volume":"33","author":"Pinto","year":"2022","journal-title":"Osteoporos Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s11658-022-00371-3","article-title":"Osteoporosis pathogenesis and treatment: existing and emerging avenues","volume":"27","author":"Liang","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2307353","article-title":"Postmenopausal osteoporosis","volume":"389","author":"Walker","year":"2023","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-024-02418-8","article-title":"Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and inflammatory joint diseases","volume":"102","author":"Martiniakova","year":"2024","journal-title":"J Mol Med Berl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413640","article-title":"Management of osteoporosis in men: a narrative review","volume":"22","author":"Vescini","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094827","article-title":"Links among obesity, type 2 diabetes mellitus, and osteoporosis: bone as a target","volume":"25","author":"Martiniakova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2024.127446","article-title":"Drug-induced osteoporosis and mechanisms of bone tissue regeneration through trace elements","volume":"84","author":"Costa","year":"2024","journal-title":"J Trace Elem Med Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108998","article-title":"Crosstalk between the gut microbiota and postmenopausal osteoporosis: mechanisms and applications","volume":"110","author":"Xu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-017-0331-y","article-title":"Gut microbiota, immune system, and bone","volume":"102","author":"D\u2019Amelio","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/biology11101402","article-title":"Roles of gut microbiome in bone homeostasis and its relationship with bone-related diseases","volume":"11","author":"Zemanova","year":"2022","journal-title":"Biol Bsl"},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","article-title":"Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bonr.2018.02.001","article-title":"Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance","volume":"8","author":"Dar","year":"2018","journal-title":"Bone Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41413-023-00264-x","article-title":"Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis","volume":"11","author":"Lyu","year":"2023","journal-title":"Bone Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00160","article-title":"Gut microbiome reveals specific dysbiosis in primary osteoporosis","volume":"10","author":"Xu","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103168","article-title":"Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis","volume":"12","author":"He","year":"2020","journal-title":"Aging Albany NY"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13527","article-title":"Compositional and functional features of the female premenopausal and postmenopausal gut microbiota","volume":"593","author":"Zhao","year":"2019","journal-title":"FEBS Lett"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1229796","article-title":"Advancing our understanding of the influence of drug induced changes in the gut microbiome on bone health","volume":"14","author":"Bailey","year":"2023","journal-title":"Front Endocrinol Lausanne"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.908727","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian Bone Club","volume":"13","author":"Laurent","year":"2022","journal-title":"Front Endocrinol Lausanne"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3280d6471a","article-title":"Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis","volume":"19","author":"Kirwan","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-7020-6896-6.00086-7","article-title":"Glucocorticoids","volume-title":"Clinical immunology","author":"Frew","year":"2019"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0341-0","article-title":"Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment","volume":"16","author":"Chotiyarnwong","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jds.2023.09.027","article-title":"Procyanidin B2 enhances anti-inflammatory responses of periodontal ligament cells by inhibiting the dominant negative pro-inflammatory isoforms of peroxisome proliferator-activated receptor \u03b3","volume":"19","author":"Yamamoto","year":"2024","journal-title":"J Dent Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702687200","article-title":"Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling","volume":"283","author":"Zhou","year":"2008","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(02)00742-1","article-title":"Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis","volume":"30","author":"Sasaki","year":"2002","journal-title":"Bone"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e3282f15407","article-title":"Glucocorticoid-induced osteoporosis","volume":"14","author":"Berris","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s00223-017-0335-7","article-title":"Glucocorticoids, inflammation and bone","volume":"102","author":"G\u00fcler-Y\u00fcksel","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.08.007","article-title":"A novel BMP2 secretagogue ameliorates glucocorticoid induced oxidative stress in osteoblasts by activating NRF2 dependent survival while promoting Wnt\/\u03b2-catenin mediated osteogenesis","volume":"190","author":"Rai","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118938","article-title":"TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosis","volume":"266","author":"Mo","year":"2021","journal-title":"Life Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9102012","article-title":"Proanthocyanidins-mediated Nrf2 activation ameliorates glucocorticoid-induced oxidative stress and mitochondrial dysfunction in osteoblasts","volume":"2020","author":"Chen","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040070","article-title":"Sensitivity of bone to glucocorticoids","volume":"107","author":"Cooper","year":"2004","journal-title":"Clin Sci Lond"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000313","article-title":"One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy","volume":"2","author":"Lems","year":"2016","journal-title":"RMD Open"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05360-w","article-title":"Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis","volume":"31","author":"Wang","year":"2020","journal-title":"Osteoporos Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001031","article-title":"Risk of fractures in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"53","author":"Komaki","year":"2019","journal-title":"J Clin Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.14309\/ajg.0000000000000062","article-title":"Fracture risk in patients with inflammatory bowel disease: a nationwide population-based cohort study from 1964 to 2014","volume":"114","author":"Ludvigsson","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s13018-020-01813-4","article-title":"Evaluation of risk factors of vertebral fracture in Japanese female patients with glucocorticoid-induced osteoporosis","volume":"15","author":"Mori","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3455-9","article-title":"Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials","volume":"27","author":"Amiche","year":"2016","journal-title":"Osteoporos Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3523","article-title":"Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions","volume":"33","author":"Balasubramanian","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1039\/c9fo01533g","article-title":"Crocin-I ameliorates the disruption of lipid metabolism and dysbiosis of the gut microbiota induced by chronic corticosterone in mice","volume":"10","author":"Xie","year":"2019","journal-title":"Food Funct"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3947","article-title":"Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis","volume":"35","author":"Schepper","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00650-21","article-title":"Integrative analysis of gut microbiota and fecal metabolites in rats after prednisone treatment","volume":"9","author":"Zhang","year":"2021","journal-title":"Microbiol Spectr"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg8335","article-title":"Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis","volume":"8","author":"Chen","year":"2022","journal-title":"Sci Adv"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.109679","article-title":"HgutMgene-Miner: in silico genome mining tool for deciphering the drug-metabolizing potential of human gut microbiome","volume":"186","author":"Amir","year":"2025","journal-title":"Comput Biol Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216225","article-title":"Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy","volume":"15","author":"Kalkan","year":"2023","journal-title":"EMBO Mol Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000332","article-title":"Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases","volume":"21","author":"Huang","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0627","article-title":"Glucocorticoid-induced bone loss: dietary supplementation recommendations to reduce the risk for osteoporosis and osteoporotic fractures","volume":"110","author":"Chen","year":"2022","journal-title":"Cutis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02467-24","article-title":"Effects of high-dose glucocorticoids on gut microbiota in the treatment of Graves\u2019 ophthalmopathy","volume":"13","author":"Su","year":"2025","journal-title":"Microbiol Spectr"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1268134","article-title":"Korean red ginseng extract prevents bone loss in an oral model of glucocorticoid induced osteoporosis in mice","volume":"15","author":"Chargo","year":"2024","journal-title":"Front Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"9064","DOI":"10.29219\/fnr.v67.9064","article-title":"Lactobacillus plantarum LP45 inhibits the RANKL\/OPG signaling pathway and prevents glucocorticoid-induced osteoporosis","volume":"67","author":"Jiang","year":"2023","journal-title":"Food Nutr Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf031","article-title":"Prevention of glucocorticoid-induced impairment of bone metabolism-a randomized, placebo-controlled, single centre proof-of-concept clinical trial","volume":"9","author":"Gregori","year":"2025","journal-title":"JBMR Plus"},{"key":"B57","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13018-025-05619-0","article-title":"Study on the mechanism of Shuanghe decoction against steroid-induced osteonecrosis of the femoral head: insights from network pharmacology, metabolomics, and gut microbiota","volume":"20","author":"Zhu","year":"2025","journal-title":"J Orthop Surg Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1285442","article-title":"Lactobacillus plantarum attenuates glucocorticoid-induced osteoporosis by altering the composition of rat gut microbiota and serum metabolic profile","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52171.x","article-title":"Aromatase inhibitors: current indications and future prospects for treatment of postmenopausal breast cancer","volume":"52","author":"Arora","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"B60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(18)30621-1","article-title":"Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology\/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Mamounas","year":"2019","journal-title":"Lancet Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.5382","article-title":"Aromatase inhibitors and bone health in women with breast cancer","volume":"24","author":"Chien","year":"2006","journal-title":"J Clin Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-319-16366-6_7","article-title":"Symptoms: aromatase inhibitor induced arthralgias","volume":"862","author":"Hershman","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666200604160614","article-title":"Are oxidative stress and inflammation mediators of bone loss due to estrogen deficiency? A review of current evidence","volume":"20","author":"Mohamad","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.713700","article-title":"Aromatase inhibitor-associated musculoskeletal syndrome: understanding mechanisms and management","volume":"12","author":"Hyder","year":"2021","journal-title":"Front Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2020.3.01","article-title":"Pharmacological agents and natural compounds: available treatments for osteoporosis","volume":"71","author":"Martiniakova","year":"2020","journal-title":"J Physiol Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00033.2015","article-title":"Estrogens and androgens in skeletal physiology and pathophysiology","volume":"97","author":"Almeida","year":"2017","journal-title":"Physiol Rev"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e403","article-title":"Osteoporotic fractures of the spine, hip, and other locations after adjuvant endocrine therapy with aromatase inhibitors in breast cancer patients: a meta-analysis","volume":"35","author":"Lee","year":"2020","journal-title":"J Korean Med Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3899-6","article-title":"Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer","volume":"28","author":"Hong","year":"2017","journal-title":"Osteoporos Int"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604700","article-title":"Extending aromatase-inhibitor adjuvant therapy to 10 years","volume":"375","author":"Goss","year":"2016","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1177\/1758834015598536","article-title":"Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidance","volume":"7","author":"Servitja","year":"2015","journal-title":"Ther Adv Med Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.1.172","article-title":"Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women","volume":"17","author":"Heshmati","year":"2002","journal-title":"J Bone Miner Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70035-X","article-title":"Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial","volume":"15","author":"Goss","year":"2014","journal-title":"Lancet Oncol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.2871","article-title":"Comparative efficacy and safety of adjuvant letrozole versus anastrozole in postmenopausal patients with hormone receptor\u2013positive, node-positive early breast cancer: final results of the randomized phase III Femara Versus Anastrozole Clinical Evaluation (FACE) trial","volume":"35","author":"Smith","year":"2017","journal-title":"J Clin Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30116-5","article-title":"Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial","volume":"19","author":"De Placido","year":"2018","journal-title":"Lancet Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2019.09.021","article-title":"Hormone and breast cancer","volume":"48","author":"Gompel","year":"2019","journal-title":"Presse Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.SABCS24-P4-11-05","article-title":"Aromatase inhibitors mediate specific gut-bug interactions to shift the microbiome and decrease inflammation during adjuvant treatment in breast cancer patients","volume":"31","author":"Cook","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12916-023-02751-8","article-title":"Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis","volume":"21","author":"Walker","year":"2023","journal-title":"BMC Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11121421","article-title":"The bio-diversity and the role of gut microbiota in postmenopausal women with luminal breast cancer treated with aromatase inhibitors: an observational cohort study","volume":"11","author":"Lasagna","year":"2022","journal-title":"Pathogens"},{"key":"B80","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00432-025-06338-z","article-title":"Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study","volume":"151","author":"Kwa","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.01.028","article-title":"Alleviating anastrozole induced bone toxicity by selenium nanoparticles in SD rats","volume":"268","author":"Vekariya","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/19.129","article-title":"Breast cancer: lifestyle, the human gut microbiota\/microbiome, and survivorship","volume":"24","author":"Bodai","year":"2020","journal-title":"Perm J"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185397","article-title":"Effectiveness of proton pump inhibitor in unexplained chronic cough","volume":"12","author":"Park","year":"2017","journal-title":"PloS One"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.12.058","article-title":"Proton pump inhibitors therapy and risk of bone diseases: an update meta-analysis","volume":"218","author":"Liu","year":"2019","journal-title":"Life Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8902367","article-title":"Proton pump inhibitors and fractures in adults: a critical appraisal and review of the literature","volume":"2021","author":"Briganti","year":"2021","journal-title":"Int J Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1177\/2042098618809927","article-title":"The risks of long-term use of proton pump inhibitors: a critical review","volume":"10","author":"Jaynes","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810733","article-title":"Proton pump inhibitors and bone health: an update narrative review","volume":"23","author":"Lespessailles","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.5009\/gnl14135","article-title":"A proton pump inhibitor\u2019s effect on bone metabolism mediated by osteoclast action in old age: a prospective randomized study","volume":"9","author":"Jo","year":"2015","journal-title":"Gut Liver"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2025.101046","article-title":"Paradoxical inadequate parathyroid hormone secretion secondary to severe hypomagnesemia: a review of the literature","volume":"7","author":"Albert","year":"2025","journal-title":"Kidney Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31672","article-title":"The effects of proton pump inhibitors in acid hypersecretion-induced vitamin B12 deficiency: a systematic review (2022)","volume":"14","author":"Swarnakari","year":"2022","journal-title":"Cureus"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.331","article-title":"Proton pump inhibitor use is associated with hip fracture development: a nationwide population-based cohort study","volume":"35","author":"Min","year":"2020","journal-title":"Korean J Intern Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12478","article-title":"Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity","volume":"280","author":"Costa-Rodrigues","year":"2013","journal-title":"FEBS J"},{"key":"B93","volume-title":"FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors","year":"2025"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S223118","article-title":"The association between prolonged proton pump inhibitors use and bone mineral density","volume":"12","author":"Fattahi","year":"2019","journal-title":"Risk Manag Healthc Policy"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women\u2019s Health Initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-008-9188-4","article-title":"Increase in vertebral fracture risk in postmenopausal women using omeprazole","volume":"84","author":"Roux","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"B97","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1053\/j.gastro.2018.11.023","article-title":"Dexlansoprazole and esomeprazole do not affect bone homeostasis in healthy postmenopausal women","volume":"156","author":"Hansen","year":"2019","journal-title":"Gastroenterology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101741","article-title":"Osseous implications of proton pump inhibitor therapy: an umbrella review","volume":"20","author":"Alanazi","year":"2024","journal-title":"Bone Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae135","article-title":"Proton pump inhibitor use and bone fractures in patients with chronic kidney disease","volume":"40","author":"Kommer","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae598","article-title":"Sex-specific association of chronic proton pump inhibitor use with reduced bone density and quality","volume":"110","author":"Bioletto","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.194","article-title":"Assessing the risk of hospital-acquired Clostridium difficile infection with proton pump inhibitor use: A meta-analysis","volume":"37","author":"Arriola","year":"2016","journal-title":"Infect Ctrl Hosp Epidemiol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.2174\/1389200219666171207125351","article-title":"Adverse events of proton pump inhibitors: Potential mechanisms","volume":"19","author":"Corsonello","year":"2018","journal-title":"Curr Drug Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310376","article-title":"Proton pump inhibitors affect the gut microbiome","volume":"65","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310861","article-title":"Proton pump inhibitors alter the composition of the gut microbiota","volume":"65","author":"Jackson","year":"2016","journal-title":"Gut"},{"key":"B105","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12866-023-02895-w","article-title":"Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Microbiol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00302","article-title":"Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and hepatitis B and C-infected patients treated with ART","volume":"10","author":"Dalla Grana","year":"2019","journal-title":"Front Endocrinol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4754","article-title":"PPI-induced changes in plasma metabolite levels influence total hip bone mineral density in a UK cohort","volume":"38","author":"Zhang","year":"2023","journal-title":"J Bone Miner Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/hiv.12716","article-title":"Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch","volume":"20","author":"Moreno","year":"2019","journal-title":"HIV Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society-USA Panel","volume":"316","author":"G\u00fcnthard","year":"2016","journal-title":"JAMA"},{"key":"B110","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2020.05.008","article-title":"Osteopenia and osteoporosis among treatment-experienced people living with HIV","volume":"24","author":"Lara","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"B112","doi-asserted-by":"publisher","first-page":"7838","DOI":"10.1038\/s41598-018-26312-9","article-title":"HIV and vertebral fractures: a systematic review and metanalysis","volume":"8","author":"Ilha","year":"2018","journal-title":"Sci Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-7","article-title":"Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients","volume":"13","author":"Ansemant","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00005","article-title":"Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1363-6","article-title":"Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women","volume":"22","author":"Yin","year":"2011","journal-title":"Osteoporos Int"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193679","article-title":"Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection","volume":"13","author":"Vlot","year":"2018","journal-title":"PloS One"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study","volume":"51","author":"Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0665-z","article-title":"Osteoporosis-related fractures in HIV-infected patients receiving long-term tenofovir disoproxil fumarate: An observational cohort study","volume":"41","author":"Komatsu","year":"2018","journal-title":"Drug Saf"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2013.0252","article-title":"Long-term use of protease inhibitors is associated with bone mineral density loss","volume":"30","author":"Kinai","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients","volume":"23","author":"Duvivier","year":"2009","journal-title":"AIDS"},{"key":"B122","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/QAD.0000000000001725","article-title":"Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health","volume":"32","author":"McComsey","year":"2018","journal-title":"AIDS"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12123","article-title":"Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks","volume":"15","author":"Bloch","year":"2014","journal-title":"HIV Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku300","article-title":"Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)","volume":"69","author":"Negredo","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003400","article-title":"Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection","volume":"37","author":"Mei","year":"2023","journal-title":"AIDS"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.18878","article-title":"The impact of HIV antiretroviral therapy on gut microbiota: the need for well-designed longitudinal studies","volume":"18","author":"Dolo","year":"2024","journal-title":"J Infect Dev Ctries"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000869","article-title":"Gut microbiota diversity predicts immune status in HIV-1 infection","volume":"29","author":"Nowak","year":"2015","journal-title":"AIDS"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001409","article-title":"Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria","volume":"31","author":"Nowak","year":"2017","journal-title":"AIDS"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/srep43741","article-title":"Fecal bacterial communities in treated HIV infected individuals on two antiretroviral regimens","volume":"7","author":"Pinto-Cardoso","year":"2017","journal-title":"Sci Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00502","article-title":"Influence of HIV infection and antiretroviral therapy on bone homeostasis","volume":"11","author":"Delpino","year":"2020","journal-title":"Front Endocrinol Lausanne"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-00946-4","article-title":"Osteoporosis and HIV infection","volume":"110","author":"Biver","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17822","article-title":"The extent of cytochrome P450 3A induction by antiseizure medications: A systematic review and network meta-analysis","volume":"65","author":"Cohen","year":"2024","journal-title":"Epilepsia"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.3c00613","article-title":"Anticonvulsant classes and possible mechanism of actions","volume":"14","author":"Abd-Allah","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105230","article-title":"Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies","volume":"115","author":"Pal","year":"2021","journal-title":"Bioorg Chem"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116476","article-title":"Twenty-first century antiepileptic drugs. An overview of their targets and synthetic approaches","volume":"272","author":"S\u00e1nchez","year":"2024","journal-title":"Eur J Med Chem"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2014.04.016","article-title":"P450 enzyme-inducing and non-enzyme-inducing antiepileptic drugs for seizure prophylaxis after glioma resection surgery: a meta-analysis","volume":"23","author":"Yuan","year":"2014","journal-title":"Seizure"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101755","article-title":"Impaired bone health as a co-morbidity of epilepsy","volume":"36","author":"Andersen","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212139","article-title":"Primary osteoporosis induced by androgen and estrogen deficiency: The molecular and cellular perspective on pathophysiological mechanisms and treatments","volume":"25","author":"Hsu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25693","article-title":"Homocysteine as a pathological biomarker for bone disease","volume":"232","author":"Behera","year":"2017","journal-title":"J Cell Physiol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1186\/s13018-023-04169-7","article-title":"Carbamazepine regulates USP10 through miR-20a-5p to affect the deubiquitination of SKP2 and inhibit osteogenic differentiation","volume":"18","author":"Wang","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.seizure.2019.10.017","article-title":"Effects of valproic acid on bone mineral density and bone metabolism: A meta-analysis","volume":"73","author":"Fan","year":"2019","journal-title":"Seizure"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05926-2","article-title":"High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs","volume":"32","author":"Dussault","year":"2021","journal-title":"Osteoporos Int"},{"key":"B145","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12891-021-04042-w","article-title":"Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study","volume":"22","author":"Chandrasekaran","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01088-x","article-title":"Sex differences in adverse effects of antiseizure medications in adults with epilepsy: A systematic review","volume":"38","author":"Giuliano","year":"2024","journal-title":"CNS Drugs"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17733","article-title":"Both epilepsy and anti-seizure medications affect bone metabolism in children with self-limited epilepsy with centrotemporal spikes","volume":"64","author":"Shi","year":"2023","journal-title":"Epilepsia"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13893","article-title":"Impaired bone and muscle development in young people treated with antiepileptic drugs","volume":"58","author":"Simm","year":"2017","journal-title":"Epilepsia"},{"key":"B149","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.seizure.2012.10.002","article-title":"Fracture risk with use of liver enzyme inducing antiepileptic drugs in people with active epilepsy: cohort study using the general practice research database","volume":"22","author":"Nicholas","year":"2013","journal-title":"Seizure"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106619","article-title":"The effects of antiepileptic drugs on bone health: A systematic review","volume":"173","author":"Griepp","year":"2021","journal-title":"Epilepsy Res"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/nu7125517","article-title":"Greater calcium intake is associated with better bone health measured by quantitative ultrasound of the phalanges in pediatric patients treated with anticonvulsant drugs","volume":"7","author":"Vera","year":"2015","journal-title":"Nutrients"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15767","article-title":"The microbiome-gut-brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications","volume":"30","author":"Kundu","year":"2023","journal-title":"Eur J Neurol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115576","article-title":"Evidences for a role of gut microbiota in pathogenesis and management of epilepsy","volume":"22","author":"Amlerova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat9931","article-title":"Separating host and microbiome contributions to drug pharmacokinetics and toxicity","volume":"363","author":"Zimmermann","year":"2019","journal-title":"Science"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105340","article-title":"Analysis of gut microbiota in patients with epilepsy treated with valproate: results from a three months observational prospective cohort study","volume":"162","author":"Gong","year":"2022","journal-title":"Microb Pathog"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1242856","article-title":"Topiramate alters the gut microbiome to aid in its anti-seizure effect","volume":"14","author":"Thai","year":"2023","journal-title":"Front Microbiol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.0c03075","article-title":"Antibiotic resistance in the collembolan gut microbiome accelerated by the nonantibiotic drug carbamazepine","volume":"54","author":"Wang","year":"2020","journal-title":"Environ Sci Technol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1004366","article-title":"Use of antipsychotic medication and its relationship with bone mineral density: a population-based study of men and women","volume":"13","author":"Azimi Manavi","year":"2022","journal-title":"Front Psychiatry"},{"key":"B159","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/acps.13669","article-title":"Antipsychotic agents in anxiety disorders: an umbrella review","volume":"149","author":"Garakani","year":"2024","journal-title":"Acta Psychiatr Scand"},{"key":"B160","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s40429-025-00690-3","article-title":"Interactions among substance use disorders, inflammation, and bone health: a crucial role of the brain-bone axis","volume":"12","author":"Martiniakova","year":"2025","journal-title":"Curr Addict Rep"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1184550","article-title":"Antipsychotic-induced bone loss: the role of dopamine, serotonin and adrenergic receptor signalling","volume":"11","author":"Weerasinghe","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup","year":"2018","journal-title":"World Psychiatry"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1257460","article-title":"Second-generation antipsychotics and metabolic syndrome: a role for mitochondria","volume":"14","author":"Mortimer","year":"2023","journal-title":"Front Psychiatry"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14232745","article-title":"The association between antipsychotics and bone fragility: an updated comprehensive review","volume":"14","author":"Mercurio","year":"2024","journal-title":"Diag Bsl"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.4103\/1658-631X.188246","article-title":"Low bone mass secondary to antipsychotic medications","volume":"4","author":"Al-Omran","year":"2016","journal-title":"Saudi J Med Med Sci"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01041-3","article-title":"Hyperprolactinemia and bone","volume":"23","author":"di Filippo","year":"2020","journal-title":"Pituitary"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyae059.612","article-title":"Impact of antipsychotics on prolactin levels in pediatric and adolescent patients with psychiatric disorders in real-world psychiatric clinical practice","volume":"28","author":"Wada","year":"2025","journal-title":"Int J Neuropsychopharmacol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1038\/s41598-021-84606-x","article-title":"Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas","volume":"11","author":"Andereggen","year":"2021","journal-title":"Sci Rep"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2017.0158","article-title":"Hormonal risk factors for osteoporosis: different profile among antipsychotics","volume":"28","author":"Raffin","year":"2018","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pharmthera.2018.06.012","article-title":"Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences","volume":"192","author":"Aringhieri","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1177\/2045125313487548","article-title":"Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents","volume":"3","author":"Calarge","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3881-3","article-title":"Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis","volume":"28","author":"Lee","year":"2017","journal-title":"Osteoporos Int"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115974","article-title":"Comparative analysis of psychiatric medications and their association with falls and fractures: a systematic review and network meta-analysis","volume":"338","author":"Guo","year":"2024","journal-title":"Psychiatry Res"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221948","article-title":"The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: a retrospective cohort study","volume":"14","author":"Shen","year":"2019","journal-title":"PloS One"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q589","article-title":"Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs","volume":"46","author":"Oderda","year":"2012","journal-title":"Ann Pharmacother"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000221","article-title":"Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"33","author":"Papola","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9080875","article-title":"Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics","volume":"9","author":"Manchia","year":"2021","journal-title":"Biomedicines"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-018-5102-6","article-title":"Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome","volume":"236","author":"Skonieczna-\u017bydecka","year":"2019","journal-title":"Psychopharmacol Berl"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacol Berl"},{"key":"B180","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41398-018-0116-8","article-title":"Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota","volume":"8","author":"Kao","year":"2018","journal-title":"Transl Psychiatry"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101605","article-title":"Analysis of gut microbiota and their metabolic potential in patients with schizophrenia treated with olanzapine: results from a six-week observational prospective cohort study","volume":"8","author":"Pe\u0142ka-Wysiecka","year":"2019","journal-title":"J Clin Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.135","article-title":"Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children","volume":"5","author":"Bahr","year":"2015","journal-title":"Transl Psychiatry"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087326","article-title":"Evidence of the dysbiotic effect of psychotropics on gut microbiota and capacity of probiotics to alleviate related dysbiosis in a model of the human colon","volume":"24","author":"Ait Chait","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70255","article-title":"Comprehensive characterization of antidepressant pharmacogenetics: a systematic review of studies in major depressive disorder","volume":"18","author":"Grant","year":"2025","journal-title":"Clin Transl Sci"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-024-01815-4","article-title":"Reply to Sun: dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection","volume":"49","author":"Frye","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis","volume":"51","author":"Rizzoli","year":"2012","journal-title":"Bone"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2024.10.114","article-title":"Examining depression, antidepressants use, and class and their potential associations with osteoporosis and fractures in adult women: results from ten NHANES cohorts","volume":"369","author":"Rajha","year":"2025","journal-title":"J Affect Disord"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-012-0105-0","article-title":"The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women","volume":"7","author":"Erez","year":"2012","journal-title":"Arch Osteoporos"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.11.019","article-title":"The association between depressive and anxiety symptoms and bone mineral density in the general population: the HUNT study","volume":"131","author":"Williams","year":"2011","journal-title":"J Affect Disord"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1708\/2002.21642","article-title":"Osteoporosis and major depression: open debate on a bidirectional relationship","volume":"50","author":"Carlone","year":"2015","journal-title":"Riv Psichiatr"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200307000-00013","article-title":"Mechanisms of glucocorticoid-induced osteoporosis","volume":"15","author":"Canalis","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.18413\/2658-6533-2022-8-4-0-5","article-title":"The role of cortisol metabolism in the realization of pathogenetic links in the development of osteoporosis \u2013 the rationale for the search for new pharmacotherapeutic targets","volume":"8","author":"Korokin","year":"2022","journal-title":"Res Results BioMed"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152868","article-title":"A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice","volume":"132","author":"Luo","year":"2022","journal-title":"J Clin Invest"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.07.083","article-title":"Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management","volume":"46","author":"Haney","year":"2010","journal-title":"Bone"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.52965\/001c.38564","article-title":"The use of antidepressants is linked to bone loss: a systematic review and metanalysis","volume":"14","author":"Mercurio","year":"2022","journal-title":"Orthop Rev Pavia"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31817e0ecb","article-title":"Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures","volume":"28","author":"Ziere","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.2.188","article-title":"Effect of selective serotonin reuptake inhibitors on the risk of fracture","volume":"167","author":"Richards","year":"2007","journal-title":"Arch Intern Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2024.101538","article-title":"Comparison of the effect of selective serotonin and norepinephrine reuptake inhibitors on bone mineral density with selective serotonin reuptake inhibitors and healthy controls","volume":"28","author":"Do\u011fan Bulut","year":"2025","journal-title":"J Clin Densitom"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115552","article-title":"Current anti-depressant use is associated with cortical bone deficits and reduced physical function in elderly women","volume":"140","author":"Agarwal","year":"2020","journal-title":"Bone"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1971","article-title":"Rates of bone loss among women initiating antidepressant medication use in midlife","volume":"98","author":"Diem","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B201","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1038\/s41598-021-94481-1","article-title":"The change of gut microbiota in MDD patients under SSRIs treatment","volume":"11","author":"Shen","year":"2021","journal-title":"Sci Rep"},{"key":"B202","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1038\/s41467-018-05184-7","article-title":"Gut microbiota associations with common diseases and prescription medications in a population-based cohort","volume":"9","author":"Jackson","year":"2018","journal-title":"Nat Commun"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1869501","article-title":"Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain","volume":"13","author":"Deng","year":"2021","journal-title":"Gut Microbes"},{"key":"B204","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41398-021-01428-1","article-title":"Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment","volume":"11","author":"Duan","year":"2021","journal-title":"Transl Psychiatry"},{"key":"B205","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41398-019-0466-x","article-title":"Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior","volume":"9","author":"Luki\u0107","year":"2019","journal-title":"Transl Psychiatry"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2023.109466","article-title":"Beneficial effects of arketamine on the reduced bone mineral density in susceptible mice after chronic social defeat stress: Role of the gut-microbiota-bone-brain axis","volume":"228","author":"Wan","year":"2023","journal-title":"Neuropharmacology"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/9vqg6f","article-title":"Drug-induced osteoporosis\/osteopenia: a pharmacovigilance analysis using the FDA Adverse Event Reporting System database","volume":"44","author":"Wang","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1630412","article-title":"Sex differences in drug-induced osteoporosis: a pharmacovigilance study based on the FAERS database","volume":"13","author":"Liu","year":"2025","journal-title":"Front Public Health"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.101128","article-title":"Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients","volume":"15","author":"Makras","year":"2021","journal-title":"Bone Rep"},{"key":"B211","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.seizure.2021.08.009","article-title":"Incidence of clinical fractures: A 7-year follow-up study in institutionalized adults with epilepsy and intellectual disability","volume":"92","author":"Berkvens","year":"2021","journal-title":"Seizure"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116003","article-title":"Osteoporosis medication is associated with mortality risk reduction among adults with epilepsy: An observational study","volume":"150","author":"Whitney","year":"2021","journal-title":"Bone"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-022-01393-9","article-title":"Efficacy of denosumab on bisphosphonate-treated osteoporosis and osteopenia in systemic rheumatic disease patients receiving glucocorticoids","volume":"41","author":"Tamechika","year":"2023","journal-title":"J Bone Miner Metab"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12891-022-05997-0","article-title":"Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis","volume":"23","author":"Jiang","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3534-6","article-title":"Teriparatide for osteoporosis: importance of the full course","volume":"27","author":"Lindsay","year":"2016","journal-title":"Osteoporos Int"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1055\/a-2015-1747","article-title":"Comparison of bisphosphonates versus teriparatide in therapy of the glucocorticoid-induced osteoporosis (GIOP): a meta-analysis of randomized controlled trials","volume":"55","author":"Dong","year":"2023","journal-title":"Horm Metab Res"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020164","article-title":"Prolonged impact of bisphosphonates and glucocorticoids on bone mechanical properties","volume":"18","author":"Mansour","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S31067","article-title":"Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis","volume":"7","author":"Dore","year":"2013","journal-title":"Patient Pref Adherence"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1818207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T04:19:31Z","timestamp":1780287571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1818207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":218,"alternative-id":["10.3389\/fendo.2026.1818207"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1818207","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"1818207"}}